Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease

[1]  Nick C Fox,et al.  Shining a light on posterior cortical atrophy , 2013, Alzheimer's & Dementia.

[2]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[3]  Kewei Chen,et al.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study , 2012, The Lancet Neurology.

[4]  Nick C. Fox,et al.  Global gray matter changes in posterior cortical atrophy: A serial imaging study , 2012, Alzheimer's & Dementia.

[5]  Susan M. Resnick,et al.  Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort , 2012, Alzheimer's & Dementia.

[6]  C. Jack,et al.  Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.

[7]  P. Scheltens,et al.  Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers , 2012, Neurobiology of Aging.

[8]  Josephine Barnes,et al.  Early-onset Alzheimer disease clinical variants , 2012, Neurology.

[9]  Henrik Zetterberg,et al.  Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly , 2012, Neurobiology of Aging.

[10]  Frederik Barkhof,et al.  Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. , 2012, Brain : a journal of neurology.

[11]  G. Frisoni,et al.  Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage , 2012, Neurobiology of Aging.

[12]  Eini Niskanen,et al.  Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. , 2012, Current Alzheimer research.

[13]  Frederik Barkhof,et al.  Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  C. Jack,et al.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics , 2012, Brain : a journal of neurology.

[15]  Nick C Fox,et al.  Posterior cortical atrophy , 2012, The Lancet Neurology.

[16]  R. Petersen,et al.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.

[17]  Mike P. Wattjes,et al.  Visual assessment of posterior atrophy development of a MRI rating scale , 2011, European Radiology.

[18]  Philip Scheltens,et al.  Early-onset Alzheimer's disease is associated with a distinct neuropsychological profile , 2011, Alzheimer's & Dementia.

[19]  J. Molinuevo,et al.  Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease , 2011, Neurology.

[20]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[21]  Nick C Fox,et al.  Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele , 2011, The Lancet Neurology.

[22]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[23]  Ulrich Seidl,et al.  Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[24]  Hilkka Soininen,et al.  Longitudinal changes of CSF biomarkers in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[25]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[26]  Cornelis J Stam,et al.  EEG abnormalities in early and late onset Alzheimer's disease: understanding heterogeneity , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  G. Ridgway.  CLINICAL SYNDROMES ASSOCIATED WITH POSTERIOR ATROPHY: EARLY AGE AT ONSET AD SPECTRUM , 2010, Neurology.

[28]  Nick C Fox,et al.  Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease , 2010, American Journal of Neuroradiology.

[29]  W. M. van der Flier,et al.  Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. , 2010, Clinical chemistry.

[30]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[31]  Wiesje M van der Flier,et al.  Early-versus late-onset Alzheimer's disease: more than age alone. , 2010, Journal of Alzheimer's disease : JAD.

[32]  L H Kuller,et al.  Age, Alzheimer disease, and brain structure , 2009, Neurology.

[33]  Nick C. Fox,et al.  Patterns of Cortical Thickness according to APOE Genotype in Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.

[34]  Andrew J. Saykin,et al.  Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.

[35]  Paul M. Thompson,et al.  Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo , 2009, NeuroImage.

[36]  Giovanni Defazio,et al.  Rate of MMSE score change in Alzheimer's disease: Influence of education and vascular risk factors , 2009, Clinical Neurology and Neurosurgery.

[37]  W. M. van der Flier,et al.  Most rapid cognitive decline in APOE ε4 negative Alzheimer's disease with early onset , 2009, Psychological Medicine.

[38]  M. Battaglini,et al.  Early structural changes in individuals at risk of familial Alzheimer’s disease: a volumetry and magnetization transfer MR imaging study , 2009, Journal of Neurology.

[39]  Thomas E. Nichols,et al.  Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease , 2009, NeuroImage.

[40]  Sébastien Ourselin,et al.  Issues with threshold masking in voxel-based morphometry of atrophied brains , 2009, NeuroImage.

[41]  M. Mintun,et al.  Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. , 2008, Archives of neurology.

[42]  B. Miller,et al.  The logopenic/phonological variant of primary progressive aphasia , 2008, Neurology.

[43]  S. Morikawa,et al.  Different Atrophic Patterns in Early- and Late-Onset Alzheimer’s Disease and Evaluation of Clinical Utility of a Method of Regional z-Score Analysis Using Voxel-Based Morphometry , 2008, Dementia and Geriatric Cognitive Disorders.

[44]  Nancy Johnson,et al.  Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia , 2008, Annals of neurology.

[45]  F. Pasquier,et al.  Cognitive Decline and Survival in Alzheimer’s Disease according to Education Level , 2007, Dementia and Geriatric Cognitive Disorders.

[46]  S. Studenski,et al.  Gait Variability Is Associated with Subclinical Brain Vascular Abnormalities in High-Functioning Older Adults , 2007, Neuroepidemiology.

[47]  Martin Klein,et al.  Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study , 2007, Neuroradiology.

[48]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[49]  W. M. van der Flier,et al.  Longitudinal changes of CSF biomarkers in memory clinic patients , 2007, Neurology.

[50]  C. Jack,et al.  Imaging correlates of posterior cortical atrophy , 2007, Neurobiology of Aging.

[51]  F. Schmitt,et al.  Age and gender effects on human brain anatomy: A voxel-based morphometric study in healthy elderly , 2007, Neurobiology of Aging.

[52]  J. Cummings,et al.  Early-Onset Alzheimer’s Disease Is Associated With Greater Pathologic Burden , 2007, Journal of geriatric psychiatry and neurology.

[53]  Kiralee M. Hayashi,et al.  The topography of grey matter involvement in early and late onset Alzheimer's disease. , 2007, Brain : a journal of neurology.

[54]  C. Junqué,et al.  Mild Cognitive Impairment after Lacunar Infarction: Voxel-Based Morphometry and Neuropsychological Assessment , 2007, Cerebrovascular Diseases.

[55]  Masayuki Matsuda,et al.  Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease , 2006, NeuroImage.

[56]  Denis A. Evans,et al.  Cognitive decline and survival in Alzheimer's disease , 2006, International journal of geriatric psychiatry.

[57]  W. M. van der Flier,et al.  Hippocampal atrophy in Alzheimer disease: Age matters , 2006, Neurology.

[58]  M. Merzenich,et al.  Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. , 2006, Progress in brain research.

[59]  Sue J. Kang,et al.  Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. , 2005, Brain : a journal of neurology.

[60]  K. Ishii,et al.  Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. , 2005, AJNR. American journal of neuroradiology.

[61]  G. Frisoni,et al.  Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[62]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[63]  M. Greicius,et al.  Presenile dementia syndromes: an update on taxonomy and diagnosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[64]  Frederik Barkhof,et al.  Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion , 2002, The Lancet Neurology.

[65]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[66]  Hiroaki Kazui,et al.  Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease , 2001, Neurology.

[67]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[68]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[69]  E. Mori,et al.  Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. , 2001, Neurology.

[70]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[71]  K Patterson,et al.  Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. , 2000, Brain : a journal of neurology.

[72]  Y. Stern,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[73]  R. Mohs,et al.  Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease , 1996, Neurology.

[74]  M. Albert,et al.  Age at onset of Alzheimer's disease , 1994, Neurology.

[75]  P. Scheltens,et al.  Brain imaging and Alzheimer's disease , 1993, European Neuropsychopharmacology.

[76]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[77]  J. Cervós-Navarro,et al.  Selective vulnerability in brain hypoxia. , 1991, Critical reviews in neurobiology.

[78]  J. Harrison,et al.  Posterior cortical atrophy. , 1989, Clinical and experimental neurology.

[79]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[80]  L. Iversen,et al.  Neurochemical characteristics of early and late onset types of Alzheimer's disease. , 1984, British medical journal.